DNA Template Preparation Service
The quality of a therapeutic mRNA molecule is fundamentally determined by the DNA template from which it is transcribed. In the complex landscape of mRNA-based vaccine development, the DNA template serves as the master blueprint, encoding not only the target antigen but also the critical regulatory elements, such as the 5' and 3' untranslated regions (UTRs) and the poly(A) tail, that dictate stability and translation efficiency. CD BioGlyco provides a specialized DNA template preparation service designed to eliminate the common bottlenecks of in vitro transcription (IVT). We focus on delivering high-purity, sequence-verified, and perfectly linearized DNA templates that minimize transcriptional read-through and double-stranded RNA (dsRNA) formation. By ensuring the integrity of the genetic starting material, we enable researchers to produce mRNA with superior potency and reduced immunogenicity, accelerating the transition from sequence design to clinical application.
To provide templates that meet the rigorous standards of modern biophysics, we utilize several proprietary and advanced technological platforms:
Utilizing high-fidelity type IIS restriction enzymes or customized endonucleases, we ensure 100% linearization of circular plasmids. This prevents "run-on" transcription, which is a primary source of impurity in mRNA synthesis.
Our optimized E. coli strains and fermentation protocols are designed to maximize plasmid yield while maintaining a high percentage of supercoiled DNA, which is essential for stable storage and efficient processing.
We employ multi-step purification strategies, including anion-exchange (AEX) and hydrophobic interaction chromatography (HIC), to achieve ultra-low endotoxin levels and remove host-cell proteins or residual genomic DNA.
Every template undergoes deep-sequencing or long-read sequencing (SMRT technology) to verify the accuracy of repetitive regions, particularly long poly(A) tracts that are prone to recombination or deletion during bacterial replication.
The DNA template preparation service is built to support the entire lifecycle of mRNA vaccine and therapeutic development. Our scope ranges from small-scale pilot studies (milligram quantities) for initial screening to large-scale template production (gram quantities) for late-stage pre-clinical batches. We specialize in complex sequences, including those with high GC content, secondary structures, or exceptionally long poly(A) tails (up to 120-150 bp). Beyond standard plasmid DNA, our scope includes the preparation of PCR-based templates for rapid prototyping. We provide specialized services for self-amplifying RNA (saRNA) templates and circular RNA (circRNA) precursors. Every project is accompanied by a detailed certificate of analysis (CoA).
We initiate the process with a comprehensive analysis of the client's target sequence. This includes codon optimization tailored to the desired expression system, GC-content adjustment, and the elimination of destabilizing motifs. The DNA is then chemically synthesized with high fidelity, incorporating strategically placed restriction sites for efficient downstream linearization, along with selected 5' and 3' UTR sequences from our validated libraries to enhance mRNA stability and translational efficiency.
The synthesized gene is precisely cloned into high-copy-number, production‑grade plasmids under stringent aseptic conditions. Following sequence verification, a single validated clone is used to generate a master cell bank (MCB), which is thoroughly characterized and stored under controlled conditions. This ensures genetic consistency and provides a reproducible source of material for all future plasmid production, supporting both long-term projects and scalable manufacturing needs.
Plasmid amplification is carried out in controlled, high-density fermentation systems to achieve optimal yield while maintaining plasmid integrity. Our proprietary recovery process employs gentle lysis and purification techniques designed to minimize mechanical and shear stress on the DNA, thereby preserving the supercoiled conformation and structural integrity of the plasmid template for subsequent enzymatic steps.
The circular plasmid is converted into a linearized template using a highly specific restriction enzyme. We meticulously optimize the enzyme-to-DNA ratio, buffer composition, and incubation time to achieve complete, single-site cleavage while avoiding star activity, over-digestion, or nonspecific cutting that could compromise template quality and subsequent IVT yields.
Following linearization, the template undergoes rigorous purification to remove all enzymes, salts, and residual impurities. A comprehensive quality control battery is then performed, including capillary gel electrophoresis to confirm full-length integrity and assess nicking, HPLC analysis to verify purity, and sensitive limulus amebocyte lysate (LAL) testing to ensure endotoxin levels are within the specified limits for IVT applications.
The purified linear DNA template is formulated into the client's specified buffer, such as TE buffer or nuclease-free water, and accurately quantified. Each batch is aseptically aliquoted into single-use volumes, labeled, and documented, providing a ready-to-use template at a defined concentration, optimized for immediate and efficient use in large-scale IVT reactions.
Journal: Accounts of Chemical Research
DOI: 10.1021/acs.accounts.7b00280
IF: 17.7
Published: 2017
Results: This article chronicles the evolution of DNA-templated synthesis (DTS) as a powerful tool for materials discovery, positioning it as a transformative methodology that leverages the programmability of DNA to control chemical reactions. The authors explain how DTS overcomes the limitations of traditional combinatorial chemistry by using DNA hybridization to bring building blocks into close proximity, enabling parallel synthesis of vast molecular libraries in a single pot and efficiently searching chemical spaces orders of magnitude larger than previously possible. They detail key architectural strategies, such as templated parallel, templated sequential, and autonomous systems, that facilitate the programmed assembly of diverse structures, from oligomers to macrocycles. A central theme is the potential for molecular evolution, where DNA encoding allows for iterative cycles of synthesis, selection, and amplification to identify functional molecules, mirroring natural selection. The review highlights successful applications in drug lead discovery and underscores the potential of DTS to revolutionize the development of advanced materials for challenges like light harvesting or carbon sequestration, while also discussing remaining challenges in reaction scope and system autonomy that must be addressed to fully realize this promise.
Protein Replacement Therapy
Develop templates for long-term protein expression. We optimize the UTRs and poly(A) regions to ensure that mRNA for metabolic enzymes or structural proteins remains stable and active for extended periods.
CRISPR/Cas9 Components
Prepare high-quality DNA templates for the transcription of Cas9, Cpf1, or guide RNA. Our clean linearization ensures that gene-editing components are produced with minimal truncated variants, improving editing efficiency.
Cell Reprogramming (iPSCs)
Utilize our templates to generate mRNAs encoding transcription factors. The ultra-pure nature of our DNA prevents the induction of interferon-mediated cell death during the reprogramming of somatic cells into stem cells.
Rare Disease Research
Target genetic disorders with bespoke DNA templates. We specialize in the difficult-to-clone sequences often associated with rare genetic conditions, providing a reliable source for therapeutic development.
Superior Poly(A) Tail Stability
We have developed proprietary bacterial strains that significantly reduce the risk of poly(A) tail shrinkage during plasmid propagation. Tail integrity is the single most important factor for mRNA half-life in the cytoplasm.
Unmatched Linearization Efficiency
Our optimized enzymatic digestion protocols ensure that virtually zero circular plasmid remains in the final product. This prevents the formation of "infinite" mRNA transcripts that can complicate purification and trigger unwanted immune responses.
Customizable UTR Integration
We offer a curated library of high-performance 5' and 3' UTRs. Using our templates, clients have achieved up to a 5-fold increase in protein expression compared to standard viral-derived UTRs.
Minimized Host Cell Contaminants
Our multi-modal chromatography platform effectively removes residual E. coli DNA and RNA. This ensures that the subsequent IVT reaction is not inhibited by impurities, leading to higher mRNA yields and better quality.
The DNA templates from CD BioGlyco transformed our mRNA yields. Their linearization is the cleanest we've seen, which practically eliminated our dsRNA contamination issues overnight.
— By Dr. A.K., Senior Scientist
CD BioGlyco is more than a vendor; they are a partner. Their technical advice on UTR placement in the DNA template helped us double our antigen expression in our latest vaccine trial.
— By Dr. K.W., VP of R&D
The low endotoxin levels in CD BioGlyco's DNA are industry-leading. We never have to worry about background inflammatory signals in our mouse models when using their templates.
— By Director, Biologics
Quantifying residual enzymes from the template prep and IVT stages to ensure final product purity.
Verifying that the mRNA transcribed from our templates is efficiently and correctly capped for maximum translation.
Using high-resolution mapping to confirm that the final mRNA product perfectly matches the DNA template sequence.
Assessing the biological activity of mRNA generated from our optimized templates in relevant cell-based models.
CD BioGlyco is committed to providing the highest quality genetic foundations for the next generation of mRNA medicines. Our DNA template preparation service ensures that your therapeutic journey begins with absolute precision and purity. From sequence optimization to clinical scale-up, CD BioGlyco is your partner in genetic excellence, contact us!
Reference
